Protul Shrikant - Concepedia

Author

Protul Shrikant

Roswell Park Comprehensive Cancer Center

Also Known As

Protul A Shrikant, Protul A. Shrikant, Protul Shrikant, Protul A. Shrikant

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Ludwig Cancer Research Memorial Sloan Kettering Cancer Center Gynecologic Oncology Group University of Minnesota

About

Protul Shrikant is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	2.5K
2	Engineering	1	1	50
3	Natural Sciences	1	1	64
4	Allergy	1	1	55
5	Biochemistry	1	1	64

Protul Shrikant

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Tumor-infiltrating NY-ESO-1–specific CD8 <sup>+</sup> T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer Junko Matsuzaki, Sacha Gnjatic, Paulette Mhawech‐Fauceglia, Proceedings of the National Academy of Sciences	2010	836
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin Rajesh R. Rao, Qingsheng Li, Kunle Odunsi, Immunity Signal TransductionAdaptive Immune SystemReceptor Tyrosine KinaseT-regulatory CellImmunology	2010	630
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model Ruea-Yea Huang, Cheryl Eppolito, Shashikant Lele, Oncotarget	2015	311
CTLA-4 Blockade Reverses CD8+ T Cell Tolerance to Tumor by a CD4+ T Cell– and IL-2-Dependent Mechanism Protul Shrikant, Alexander Khoruts, Matthew F. Mescher Immunity Cancer ImmunosurveillanceCd4+ T Cell–ImmunologyTumor ImmunityIl-2-dependent Mechanism	1999	282
Transcription Factor Foxo1 Represses T-bet-Mediated Effector Functions and Promotes Memory CD8+ T Cell Differentiation Rajesh R. Rao, Qingsheng Li, Melanie Gubbels Bupp, Immunity Immunological MemoryTranscriptional RegulationSystems BiologySignal TransductionCellular Immune Response	2012	279
Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer Kunle Odunsi, Feng Qian, Junko Matsuzaki, Proceedings of the National Academy of Sciences HistocompatibilityCancer Vaccine DesignImmunologyImmunoeditingImmunodominance	2007	266
IL-21 Enhances and Sustains CD8+ T Cell Responses to Achieve Durable Tumor Immunity: Comparative Evaluation of IL-2, IL-15, and IL-21 A. P. Moroz, Cheryl Eppolito, Qingsheng Li, The Journal of Immunology	2004	262
Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models Li Shen, Michael J. Ciesielski, Swathi Ramakrishnan, PLoS ONE	2012	197
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients Kunle Odunsi, Junko Matsuzaki, Julia Karbach, Proceedings of the National Academy of Sciences	2012	195
A Central Role for mTOR Kinase in Homeostatic Proliferation Induced CD8+ T Cell Memory and Tumor Immunity Qingsheng Li, Rajesh R. Rao, Koichi Araki, Immunity Central RoleCancer ImmunosurveillanceSignal TransductionCell RegulationReceptor Tyrosine Kinase	2011	156

Page 1